Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03330561
Title PRS-343 in HER2-Positive Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

stomach cancer

esophageal cancer

urinary bladder cancer

gastroesophageal junction adenocarcinoma

Her2-receptor positive breast cancer

Therapies

PRS-343

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.